Cargando…
Anti–SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY?
Autores principales: | Chapman, Thomas P., Revés, Joana, Torres, Joana, Satsangi, Jack |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the AGA Institute
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437698/ https://www.ncbi.nlm.nih.gov/pubmed/34529994 http://dx.doi.org/10.1053/j.gastro.2021.09.019 |
Ejemplares similares
-
Steering a Course through the COVID-19 Pandemic: Should the SECURE-IBD Registry Influence Prescribing for Patients with Inflammatory Bowel Disease?
por: Gomes, Catarina Frias, et al.
Publicado: (2021) -
Adding Fuel to the Fire? A Role of Intraepithelial Lymphocytes in Enteric Immune Responses to SARS-CoV-2 Infection
por: Antia, Avan, et al.
Publicado: (2022) -
Should we test asymptomatic children for SARS-CoV-2?
por: Cowan, Kirsty, et al.
Publicado: (2021) -
How can we reduce the risks of SARS-CoV-2 (COVID-19) for dentists and their patients?
por: de Almeida Barros Mourão, Carlos Fernando, et al.
Publicado: (2020) -
por: Talwar, Sachin
Publicado: (2011)